Aroa Biosurgery’s Wound Closure Product Cleared by FDA

The FDA has granted 510(k) clearance to Australia’s Aroa Biosurgery for Symphony, a wound closure product.

The product is designed to reduce the time it takes for a wound to close, particularly for patients with seriously impaired healing or complications from other diseases.

The company said it aims to commercially launch Symphony in the U.S. next year.